BioSpace News Archive

MacroGenics, Inc. announced that the Company’s management will participate in the following investor conferences in February 2023:

Arvinas, Inc., a clinical-stage biotechnology company creating a new class of drugs based on targeted protein degradation, announced that management will participate in three upcoming investor conferences.

Azenta, Inc. will announce fiscal first quarter 2023 earnings which ended on December 31, 2022 on Wednesday, February 8, 2023 after the market closes.

Aracari Biosciences expands to new headquarters in Irvine, California after incubating for 3 years at University Lab Partners, the premier life science incubator in Irvine.

Medexus Pharmaceuticals is pleased to welcome Harmony P. Garges MD MPH, Chief Medical Officer of ViiV Healthcare, and Menassie Taddese MBA, former executive at Pfizer and Viatris, to the Medexus board of directors.

Aptorum Group Limited announced that it will hold a special extraordinary meeting of shareholders at the London office 4T.07, 17 Hanover Square, Mayfair London, England W1S 1BN at 10:00 a.m. London Time on February 21, 2023.

DiA Imaging Analysis announced today that the U.S. Food and Drug Administration (FDA) has cleared LVivo IQS, a new AI-based vendor-neutral software solution that enables ultrasound users to acquire high-quality interpretable cardiac ultrasound images that can be used to make better clinical assessments of the heart.

Vizgen Inc. will present new data supporting the exceptional sensitivity, biological accuracy, and specificity of the company’s MERSCOPE™ Platform in addition to data describing the great quality performance using highly-multiplexed 500 gene panels for Neurobiology and Oncology applications at the Advances in Genome Biology and Technology (AGBT) 2023 General Meeting, occurring February 6-9, 2023.

Qosina Corp., a leading global supplier of OEM single-use components to the medical and biopharmaceutical industries, is pleased to announce the appointment of Lee Pochter as Executive Vice President.

Last week, Memory Treatment Centers (MTC) became amongst the very first healthcare organizations within the United States to successfully begin administering Leqembi to qualified patients at its facilities.